Fesoterodin-Mepha 4 mg, Retardtabletten
7680687900027
CH-68790
Tabletten
Associated product:
FESOTERODIN Mepha cpr ret 4 mg 84 pce
1 / 3
google
Article details
- Package size
- 84
- Selling units
- 84
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
fesoterodini fumaras
|
4.0 MG | Substance | WIZUS |
|
fesoterodinum
|
3.1 MG | Substance | Wirkstoff (Principe actif) |
|
glyceroli dibehenas
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
talcum
|
- | Substance | HNIDK |
|
lactosum monohydricum
|
127.125 MG | Substance | HBESI |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
poly(alcohol vinylicus)
|
- | Substance | HNIDK |
|
talcum
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
glyceroli monocaprylocapras
|
- | Substance | HNIDK |
|
natrii laurilsulfas
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
E 132
|
- | Substance | FIMDK |
|
natrium
|
0.045 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 73.70
Specialties list
Yes
Generic
Yes
SL addition date:
01/01/2024
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 68790
- Drug name
- Fesoterodin-Mepha, Retardtabletten
- Galenic form
- RETT
- ATC Code
- G04BD11
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 27/06/2022
- Authorization expiration date
- 26/06/2027
- IT Number
- 05.02.0.
- Domain
- Human medicine
Package details
- Description (FR)
- FESOTERODIN Mepha cpr ret 4 mg 84 pce
- Description (DE)
- FESOTERODIN Mepha Ret Tabl 4 mg 84 Stk
- Market launch
- 27/06/2022
- Narcotic (BTM)
- No
Original drug
Toviaz, Retardtabletten
GTIN: 7680587430013
CHF 27.15